Common TLR5 mutations control cancer progression

Cancer Cell. 2015 Jan 12;27(1):1-3. doi: 10.1016/j.ccell.2014.12.008.

Abstract

The mechanisms regulating tumor-associated inflammation are incompletely understood. In this issue of Cancer Cell, Rutkowski and colleagues indicate that TLR5 signaling deficiency, which occurs in ∼10% of the population, changes interactions with commensal microbiota and deregulates a cascade of inflammatory events that can suppress or accelerate extraintestinal cancers.

Publication types

  • Comment

MeSH terms

  • Animals
  • Humans
  • Interleukin-17 / metabolism*
  • Interleukin-6 / metabolism*
  • Microbiota*
  • Neoplasms / immunology*
  • Neoplasms / pathology*
  • Toll-Like Receptor 5 / genetics*
  • Toll-Like Receptor 5 / metabolism*

Substances

  • Interleukin-17
  • Interleukin-6
  • Toll-Like Receptor 5